Behçet and LDH/Albumin

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-01

Study Completion Date

2023-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ABSTRACT Objective: To investigate whether the lactate dehydrogenase to albumin ratio can be used as a parameter to determine disease severity in Behçet's disease, an inflammatory disease, by comparing it to healthy controls.

Patients and Methods: In this retrospective cohort study, patients with Behçet's disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled. LDH, albumin levels, and LDH/albumin ratio of both groups were compared. Clinical findings and characteristics of Behçet's patients and disease severity were recorded and analyzed in relation to LDH/albumin ratio.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pan-immune-inflammation Value (PIN) in Behçet's Disease and Its Correlation With Disease Activity

NCT06729112

Behcet Syndrome

RECRUITING

Vascular Affection in Behcet Disease

NCT06280430

Behcet Disease and Vascular Involvement

NOT_YET_RECRUITING

C-Reactive Protein/Albumin Ratio and Acne Vulgaris

NCT06004583

Acne Vulgaris

COMPLETED

Serum Elafin and Vascular Affection in Behcet Disease

NCT06272929

Behcet Disease and Vascular Affection

NOT_YET_RECRUITING

Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease

NCT05868538

Behçet's Diseasecases

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Behcet's Disease Albumin Lactate Dehydrogenase Disease Severity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Behçet's Disease

LDH/albumin ratio

Intervention Type DIAGNOSTIC_TEST

LDH/Albumin ratios of patient and control groups were recorded.

healthy individuals

LDH/albumin ratio

Intervention Type DIAGNOSTIC_TEST

LDH/Albumin ratios of patient and control groups were recorded.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LDH/albumin ratio

LDH/Albumin ratios of patient and control groups were recorded.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with Behçet's disease aged 18-69

Exclusion Criteria

* younger than 18 years or older than 69 years, pregnant and lactating patients, patients with acute infection on admission or nutritional problems, symptomatic gastrointestinal symptoms, malignancy, hepatitis or liver disease were excluded.

Minimum Eligible Age

18 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes